Clinical Trials

Treatment trial for sexual desire in women with breast or gynecologic cancer

The purpose of this study is to see if the drug bupropion can improve sexual desire for postmenopausal women who have been diagnosed with breast cancer or gynecologic cancer (ovarian, endometrial, vulvar, cervical or vaginal) and to evaluate the side effects of the drug. Patients will be randomized into three groups:

Post-menopausal as defined by at least one of the following: 12 months (365 days) without a period, bilateral oophorectomy, at least one ovary and hysterectomy, and/or at least one ovary intact and 180 days without a period with FSH